Page 5 - Jazz Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […]

United statesPatricia carrNeenam patilStifel nicolausJazz pharmaceuticals company profileJazz pharmaceuticals trading downNews ratings for jazz pharmaceuticals dailyCovestor ltdRoyal bankCantor fitzgeraldJazz pharmaceuticalsInstitutional investors weigh in on jazz pharmaceuticalsInsider transactions at jazz pharmaceuticalsRise advisorsAnalyst recommendations for jazz pharmaceuticalsCape investment advisory inc